Par Equity

Par Equity LLP is a venture capital firm based in Edinburgh, United Kingdom, specializing in early-stage and growth investments, particularly in the technology sector. Founded in 2008, the firm targets small and medium-sized enterprises (SMEs) with high growth potential, including those in digital health technology. Par Equity primarily invests between £0.25 million and £2.5 million in companies with enterprise values up to £10 million, focusing on opportunities that involve proprietary technology and proven commercial products poised for transatlantic expansion. The firm aims to support Scottish companies looking to enter the United States market while also attracting U.S. businesses to Scotland. Par Equity operates an additional office in San Francisco, California, enhancing its capability to facilitate cross-continental investment opportunities.

Paul Atkinson

Partner

Claire Cramm

Investment Manager

Tom Croy

Investment Director

Aidan MacMillan

Investment Manager

Alastair Moore

Senior Investment Manager

Andrew Noble

Partner

Past deals in Nanotechnology

Dyneval

Series A in 2021
Dyneval specializes in portable technology for cattle semen analysis, focusing on the precise measurement of semen quality. Its innovative technology assesses semen motility under quasi-in-vivo conditions, providing valuable insights into spermatozoa behavior. By utilizing dynescan data, Dyneval aids in informing breeding plans and confirming semen quality throughout the supply chain. This approach not only enhances livestock production but also contributes to improved food security and reduced methane emissions, allowing farmers to address issues related to poor conception rates effectively.
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

iGii

Seed Round in 2020
Integrated Graphene Ltd specializes in the design and development of technology for producing 3D graphene foam. The company has created an innovative manufacturing process that allows for the rapid production of high-performing, pure graphene foam directly on various surfaces at room temperature. In addition to graphene foam, Integrated Graphene offers a range of products including biosensors, adaptors, and energy storage solutions, utilizing its Gii-sensor for real-time monitoring applications. Founded in 2016 and located in Stirling, United Kingdom, Integrated Graphene markets its products online, focusing on advancing the capabilities of graphene technology across multiple sectors.

Particle Analytics

Debt Financing in 2020
Particle Analytics Ltd. is a software company based in Edinburgh, United Kingdom, that specializes in technologies for the preparation, visualization, and analysis of simulation data related to particles and industrial bulk solids. Established in March 2015 as a spin-out from the University of Edinburgh, the company has quickly positioned itself as a disruptive force in its sector. Its software offers advanced post-processing capabilities that utilize temporal and spatial averaging techniques, enabling users to project and analyze particle information effectively. Additionally, the pre-processing tools allow for the creation and modification of geometries and meshes prior to simulation. By delivering significant efficiencies and improvements, Particle Analytics serves multinational organizations that manage large volumes of particulate solids, offering a substantial enhancement over existing solutions in the market.

Nova Pangaea Technologies (NPT)

Venture Round in 2020
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Nova Pangaea Technologies (NPT)

Venture Round in 2020
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Manus Neurodynamica

Venture Round in 2020
Manus Neurodynamica Ltd manufactures medical diagnostic technologies for neuromotor impairments, including the non-invasive diagnosis and monitoring of Parkinson’s disease. Its technologies are used in academic research, pharmaceutical research, and non-medical applications. The company was founded in 2008 and is based in North Shields, United Kingdom.

Censo

Venture Round in 2020
Censo Biotechnologies Ltd engages in the development of stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. Its induced pluripotent stem cells (iPSCs) technology enables creation of stem cells in the laboratory from any person who donates a skin or blood sample. The company provides services, such as human tissue sample procurement, iPSC generation, iPSC genome editing, differentiated cell protocol development and industrialization, production of differentiated cells of specific lineages, cell based assay development, and compound screening. Censo Biotechnologies Ltd was formerly known as Roslin Cellab Limited and changed its name to Censo Biotechnologies Ltd in May 2016. The company was founded in 2008 and is based in Edinburgh, United Kingdom with an additional office in Cambridge, United Kingdom.

Nova Pangaea Technologies (NPT)

Venture Round in 2020
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Censo

Venture Round in 2020
Censo Biotechnologies Ltd engages in the development of stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. Its induced pluripotent stem cells (iPSCs) technology enables creation of stem cells in the laboratory from any person who donates a skin or blood sample. The company provides services, such as human tissue sample procurement, iPSC generation, iPSC genome editing, differentiated cell protocol development and industrialization, production of differentiated cells of specific lineages, cell based assay development, and compound screening. Censo Biotechnologies Ltd was formerly known as Roslin Cellab Limited and changed its name to Censo Biotechnologies Ltd in May 2016. The company was founded in 2008 and is based in Edinburgh, United Kingdom with an additional office in Cambridge, United Kingdom.

Novosound

Venture Round in 2019
Novosound Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the design and manufacture of innovative ultrasound sensors aimed at various sectors, including aerospace, oil and gas, industrial, medical, veterinary, and dental. As the first spin-out from the University of the West of Scotland, the company employs advanced thin-film manufacturing techniques to overcome the limitations associated with traditional ultrasound technology. Novosound develops highly customizable and scalable solutions, producing sensors, systems, and software that facilitate high-resolution imaging for non-destructive testing and medical applications. The company's focus on cutting-edge technology positions it as a leader in the field of ultrasound imaging and measurement.

Particle Analytics

Venture Round in 2019
Particle Analytics Ltd. is a software company based in Edinburgh, United Kingdom, that specializes in technologies for the preparation, visualization, and analysis of simulation data related to particles and industrial bulk solids. Established in March 2015 as a spin-out from the University of Edinburgh, the company has quickly positioned itself as a disruptive force in its sector. Its software offers advanced post-processing capabilities that utilize temporal and spatial averaging techniques, enabling users to project and analyze particle information effectively. Additionally, the pre-processing tools allow for the creation and modification of geometries and meshes prior to simulation. By delivering significant efficiencies and improvements, Particle Analytics serves multinational organizations that manage large volumes of particulate solids, offering a substantial enhancement over existing solutions in the market.

Nova Pangaea Technologies (NPT)

Venture Round in 2019
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Censo

Venture Round in 2019
Censo Biotechnologies Ltd engages in the development of stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. Its induced pluripotent stem cells (iPSCs) technology enables creation of stem cells in the laboratory from any person who donates a skin or blood sample. The company provides services, such as human tissue sample procurement, iPSC generation, iPSC genome editing, differentiated cell protocol development and industrialization, production of differentiated cells of specific lineages, cell based assay development, and compound screening. Censo Biotechnologies Ltd was formerly known as Roslin Cellab Limited and changed its name to Censo Biotechnologies Ltd in May 2016. The company was founded in 2008 and is based in Edinburgh, United Kingdom with an additional office in Cambridge, United Kingdom.

Nova Pangaea Technologies (NPT)

Venture Round in 2019
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Nova Pangaea Technologies (NPT)

Venture Round in 2018
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Manus Neurodynamica

Venture Round in 2018
Manus Neurodynamica Ltd manufactures medical diagnostic technologies for neuromotor impairments, including the non-invasive diagnosis and monitoring of Parkinson’s disease. Its technologies are used in academic research, pharmaceutical research, and non-medical applications. The company was founded in 2008 and is based in North Shields, United Kingdom.

Particle Analytics

Venture Round in 2018
Particle Analytics Ltd. is a software company based in Edinburgh, United Kingdom, that specializes in technologies for the preparation, visualization, and analysis of simulation data related to particles and industrial bulk solids. Established in March 2015 as a spin-out from the University of Edinburgh, the company has quickly positioned itself as a disruptive force in its sector. Its software offers advanced post-processing capabilities that utilize temporal and spatial averaging techniques, enabling users to project and analyze particle information effectively. Additionally, the pre-processing tools allow for the creation and modification of geometries and meshes prior to simulation. By delivering significant efficiencies and improvements, Particle Analytics serves multinational organizations that manage large volumes of particulate solids, offering a substantial enhancement over existing solutions in the market.

Censo

Venture Round in 2018
Censo Biotechnologies Ltd engages in the development of stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. Its induced pluripotent stem cells (iPSCs) technology enables creation of stem cells in the laboratory from any person who donates a skin or blood sample. The company provides services, such as human tissue sample procurement, iPSC generation, iPSC genome editing, differentiated cell protocol development and industrialization, production of differentiated cells of specific lineages, cell based assay development, and compound screening. Censo Biotechnologies Ltd was formerly known as Roslin Cellab Limited and changed its name to Censo Biotechnologies Ltd in May 2016. The company was founded in 2008 and is based in Edinburgh, United Kingdom with an additional office in Cambridge, United Kingdom.

Novosound

Seed Round in 2018
Novosound Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the design and manufacture of innovative ultrasound sensors aimed at various sectors, including aerospace, oil and gas, industrial, medical, veterinary, and dental. As the first spin-out from the University of the West of Scotland, the company employs advanced thin-film manufacturing techniques to overcome the limitations associated with traditional ultrasound technology. Novosound develops highly customizable and scalable solutions, producing sensors, systems, and software that facilitate high-resolution imaging for non-destructive testing and medical applications. The company's focus on cutting-edge technology positions it as a leader in the field of ultrasound imaging and measurement.

Novosound

Venture Round in 2018
Novosound Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the design and manufacture of innovative ultrasound sensors aimed at various sectors, including aerospace, oil and gas, industrial, medical, veterinary, and dental. As the first spin-out from the University of the West of Scotland, the company employs advanced thin-film manufacturing techniques to overcome the limitations associated with traditional ultrasound technology. Novosound develops highly customizable and scalable solutions, producing sensors, systems, and software that facilitate high-resolution imaging for non-destructive testing and medical applications. The company's focus on cutting-edge technology positions it as a leader in the field of ultrasound imaging and measurement.

Novosound

Venture Round in 2018
Novosound Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the design and manufacture of innovative ultrasound sensors aimed at various sectors, including aerospace, oil and gas, industrial, medical, veterinary, and dental. As the first spin-out from the University of the West of Scotland, the company employs advanced thin-film manufacturing techniques to overcome the limitations associated with traditional ultrasound technology. Novosound develops highly customizable and scalable solutions, producing sensors, systems, and software that facilitate high-resolution imaging for non-destructive testing and medical applications. The company's focus on cutting-edge technology positions it as a leader in the field of ultrasound imaging and measurement.

Nova Pangaea Technologies (NPT)

Venture Round in 2017
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Nova Pangaea Technologies (NPT)

Venture Round in 2017
Nova Pangaea Technologies (NPT) produces fuel and chemical precursors from biomass waste. Nova Pangaea, founded in 2008, has developed the world’s leading continuous technology to convert biomass into three key sugars, Xylose, Mannose and Levoglucosan, leading to a wide range of chemicals and biofuel.

Particle Analytics

Venture Round in 2017
Particle Analytics Ltd. is a software company based in Edinburgh, United Kingdom, that specializes in technologies for the preparation, visualization, and analysis of simulation data related to particles and industrial bulk solids. Established in March 2015 as a spin-out from the University of Edinburgh, the company has quickly positioned itself as a disruptive force in its sector. Its software offers advanced post-processing capabilities that utilize temporal and spatial averaging techniques, enabling users to project and analyze particle information effectively. Additionally, the pre-processing tools allow for the creation and modification of geometries and meshes prior to simulation. By delivering significant efficiencies and improvements, Particle Analytics serves multinational organizations that manage large volumes of particulate solids, offering a substantial enhancement over existing solutions in the market.

Particle Analytics

Seed Round in 2016
Particle Analytics Ltd. is a software company based in Edinburgh, United Kingdom, that specializes in technologies for the preparation, visualization, and analysis of simulation data related to particles and industrial bulk solids. Established in March 2015 as a spin-out from the University of Edinburgh, the company has quickly positioned itself as a disruptive force in its sector. Its software offers advanced post-processing capabilities that utilize temporal and spatial averaging techniques, enabling users to project and analyze particle information effectively. Additionally, the pre-processing tools allow for the creation and modification of geometries and meshes prior to simulation. By delivering significant efficiencies and improvements, Particle Analytics serves multinational organizations that manage large volumes of particulate solids, offering a substantial enhancement over existing solutions in the market.

Shaw Water Engineering

Venture Round in 2010
Shaw Water is a producer of technology solutions to detect the presence of parasitic organisms in public water supplies.

Shaw Water Engineering

Venture Round in 2009
Shaw Water is a producer of technology solutions to detect the presence of parasitic organisms in public water supplies.

Shaw Water Engineering

Venture Round in 2009
Shaw Water is a producer of technology solutions to detect the presence of parasitic organisms in public water supplies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.